Elsevier

Gastrointestinal Endoscopy

Volume 77, Issue 3, March 2013, Pages 381-389.e1
Gastrointestinal Endoscopy

Original article
Clinical endoscopy
Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies

https://doi.org/10.1016/j.gie.2012.09.027Get rights and content

Background

Adenoma detection rate (ADR) has become the most important quality indicator for colonoscopy.

Objective

The aim of this study was to investigate which modifiable factors, directly related to the endoscopic procedure, influenced the ADR in screening colonoscopies.

Design

Observational, nested study.

Setting

Multicenter, randomized, controlled trials.

Patients

Asymptomatic people aged 50 to 69 years were eligible for a multicenter, randomized, controlled trial designed to compare colonoscopy and fecal immunochemical testing in colorectal cancer screening. A total of 4539 individuals undergoing a direct screening colonoscopy were included in this study.

Intervention

Colonoscopy.

Main Outcome Measurements

Bowel cleansing, sedation, withdrawal time in normal colonoscopies, and cecal intubation were analyzed as possible predictors of adenoma detection by using logistic regression analysis, adjusted for age and sex.

Results

In multivariate analysis, after adjustment for age and sex, factors independently related to the ADR were a mean withdrawal time longer than 8 minutes (odds ratio [OR] 1.51; 95% CI, 1.17-1.96) in normal colonoscopies and split preparation (OR 1.26; 95% CI, 1.01-1.57). For advanced adenomas, only withdrawal time maintained statistical significance in the multivariate analysis. For proximal adenomas, withdrawal time and cecal intubation maintained independent statistical significance, whereas only withdrawal time longer than 8 minutes and a <10-hour period between the end of preparation and colonoscopy showed independent associations for distal adenomas.

Limitations

Only endoscopic variables have been analyzed.

Conclusion

Withdrawal time was the only modifiable factor related to the ADR in colorectal cancer screening colonoscopies associated with an increased detection rate of overall, advanced, proximal, and distal adenomas.

Section snippets

Study population

A total of 5059 individuals underwent a direct colonoscopy in the COLONPREV STUDY,8 a randomized trial aimed at comparing the efficacy of 1-time colonoscopy and biennial fecal immunochemical testing for reducing CRC-related mortality. Asymptomatic men and women aged 50 to 69 years were eligible for enrollment into this study. Exclusion criteria were personal history of CRC, adenoma or inflammatory bowel disease, family history of hereditary or familial CRC (ie, >2 first-degree relatives with

Results

A total of 4539 screening colonoscopies were included. Adenoma or CRC was diagnosed in 1446 patients (31.7%), and advanced adenoma or CRC was found in 576 patients (12.7%). A total of 710 patients (15.6%) had proximal adenomas and 729 (16.1%) only distal adenomas. The mean number of adenomas was 0.57 (range 0-10). A total of 2210 individuals were male (48.7%). The mean age was 59.0 (± 5.5) years, and 2446 participants (53.9%) were aged between 50 and 59 years. The mean withdrawal time in normal

Discussion

In this study, different factors were related to the ADR, but only withdrawal time >8 minutes was associated with a higher ADR as well as advanced, proximal, and distal ADRs. Therefore, in this study, withdrawal time was the main modifiable factor related to detection of adenomas in CRC screening colonoscopies. Other modifiable factors, such as use of sedation, bowel preparation, or bowel cleansing, did not have a constant relationship with the detection of adenomas in screening colonoscopies.

References (31)

  • M.S. Sawhney et al.

    Effect of institution-wide policy of colonoscopy withdrawal time > or = 7 minutes on polyp detection

    Gastroenterology

    (2008)
  • R.H. Lee et al.

    Quality of colonoscopy withdrawal technique and variability in adenoma detection rates (with videos)

    Gastrointest Endosc

    (2011)
  • J.S. Mandel et al.

    Reducing mortality from colorectal cancer by screening for fecal occult bloodMinnesota Colon Cancer Control Study

    N Engl J Med

    (1993)
  • R.E. Schoen et al.

    Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy

    N Engl J Med

    (2012)
  • A.G. Zauber et al.

    Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths

    N Engl J Med

    (2012)
  • Cited by (109)

    • Withdrawal Time: Is Nine the New Six?

      2022, Clinical Gastroenterology and Hepatology
    View all citing articles on Scopus

    DISCLOSURE: This work was supported by grants from Asociación Española de Gastroenterología, Asociación Española contra el Cáncer (Fundación Científica and Junta de Barcelona), the Instituto de Salud Carlos III (PI08/90717, PI08/0726, INT-09/208, PI11/2630), FEDER funds, and Agència de Gestió d'Ajuts Universitaris i de Recerca (2009SGR849). CIBERehd is funded by the Instituto de Salud Carlos III. In the Basque Country, the study received additional support with grants from Obra Social de Kutxa, Diputación Foral de Gipuzkoa (DFG 07/5), Departamento de Sanidad del Gobierno Vasco, EITB-Maratoia (BIO 07/CA/19) y Acción Transversal contra el Cáncer del CIBERehd (2008). In Galicia, this work was supported by Dirección Xeral de Innovación e Xestión da Saúde Pública, Conselleria de Sanidade, Xunta de Galicia. OC-Micro instruments and fecal immunochemical tests were kindly provided by Eiken Chemical Co, Ltd, Japan and its Spanish representatives, Palex Medical and Biogen Diagnóstica; none of them were involved in the design of the study nor in the analysis or interpretation of results. Maria Rodríguez-Soler received a grant from Fundación de la Comunidad Valenciana para la Investigación en el Hospital General Universitario de Alicante and the Instituto de Salud Carlos III (Río-Hortega Grant CM11/00066). No other financial relationships relevant to this publication were disclosed.

    If you would like to chat with an author of this article, you may contact Dr Jover at [email protected].

    View full text